427 related articles for article (PubMed ID: 20693839)
1. Chemoimmunotherapy.
Emens LA
Cancer J; 2010; 16(4):295-303. PubMed ID: 20693839
[TBL] [Abstract][Full Text] [Related]
2. Chemoimmunotherapy: reengineering tumor immunity.
Chen G; Emens LA
Cancer Immunol Immunother; 2013 Feb; 62(2):203-16. PubMed ID: 23389507
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
Wu J; Waxman DJ
Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
[TBL] [Abstract][Full Text] [Related]
4. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
Pusuluri A; Wu D; Mitragotri S
J Control Release; 2019 Jul; 305():130-154. PubMed ID: 31004668
[TBL] [Abstract][Full Text] [Related]
5. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
Emens LA; Middleton G
Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
[TBL] [Abstract][Full Text] [Related]
6. Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ; Prendergast GC
Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
[TBL] [Abstract][Full Text] [Related]
7. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
[TBL] [Abstract][Full Text] [Related]
8. Augmenting the synergies of chemotherapy and immunotherapy through drug delivery.
Kim J; Manspeaker MP; Thomas SN
Acta Biomater; 2019 Apr; 88():1-14. PubMed ID: 30769136
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and tumor immunity: an unexpected collaboration.
Emens LA
Front Biosci; 2008 Jan; 13():249-57. PubMed ID: 17981543
[TBL] [Abstract][Full Text] [Related]
10. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.
Robertson-Tessi M; El-Kareh A; Goriely A
J Theor Biol; 2015 Sep; 380():569-84. PubMed ID: 26087282
[TBL] [Abstract][Full Text] [Related]
11. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
12. Immunological aspects of cancer chemotherapy.
Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
[TBL] [Abstract][Full Text] [Related]
13. [Bases on timing of combined modality of chemotherapy and immunotherapy].
Ogura T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1414-20. PubMed ID: 1697153
[TBL] [Abstract][Full Text] [Related]
14. CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.
Yan Y; Cao S; Liu X; Harrington SM; Bindeman WE; Adjei AA; Jang JS; Jen J; Li Y; Chanana P; Mansfield AS; Park SS; Markovic SN; Dronca RS; Dong H
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669928
[TBL] [Abstract][Full Text] [Related]
15. Emerging strategies in cancer therapy combining chemotherapy with immunotherapy.
Luo Q; Zhang L; Luo C; Jiang M
Cancer Lett; 2019 Jul; 454():191-203. PubMed ID: 30998963
[TBL] [Abstract][Full Text] [Related]
16. Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.
Sun L; Chen L; Li H
Int Immunopharmacol; 2019 Feb; 67():160-175. PubMed ID: 30553199
[TBL] [Abstract][Full Text] [Related]
17. Combined chemoimmunotherapy of solid tumours: improving vaccines?
Nowak AK; Lake RA; Robinson BW
Adv Drug Deliv Rev; 2006 Oct; 58(8):975-90. PubMed ID: 17005292
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.
Ramakrishnan R; Gabrilovich DI
Cancer Immunol Immunother; 2013 Mar; 62(3):405-10. PubMed ID: 23423351
[TBL] [Abstract][Full Text] [Related]
19. Mathematical Modelling and Analysis of the Tumor Treatment Regimens with Pulsed Immunotherapy and Chemotherapy.
Pang L; Shen L; Zhao Z
Comput Math Methods Med; 2016; 2016():6260474. PubMed ID: 26997972
[TBL] [Abstract][Full Text] [Related]
20. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
Radfar S; Wang Y; Khong HT
J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
